文献速递皮肤肿瘤

德国皮肤黑色素瘤发病率和死亡率的时间趋势

Time trends in incidence and mortality of cutaneous melanoma in Germany.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-04-17

该研究基于德国癌症登记中心(1999-2012年)和萨尔州癌症登记处(1970-2012年)数据,分析皮肤黑色素瘤年龄标化和粗发病率与死亡率趋势,并外推至2030年。结果显示德国发病率持续上升,男性粗死亡率增加,预计未来发病率将进一步上升而无平台期迹象。

要点

  • 1999至2012年德国年龄标化发病率上升55%至19.2/10万,粗发病率上升77%至26.0/10万。
  • 同期年龄标化死亡率保持稳定,但男性粗死亡率上升58%至4.1/10万,女性上升30%至3.0/10万。
  • 预计2030年男性粗发病率升至44-46/10万,女性升至38-40/10万,≥60岁人群增幅最大。

核心结论

  • 德国皮肤黑色素瘤发病率和死亡率持续增加,因人口老龄化和已累积的高紫外线暴露,预计未来发病率进一步上升且无平台期迹象。

研究设计与样本

  • 研究评估德国癌症登记中心1999-2012年数据和萨尔州癌症登记处1970-2012年数据,分析年龄标化(根据欧洲标准人口,WHO 1976)及粗发病率和死亡率,并外推至2030年。

主要发现

  • 1999至2012年全德国年龄标化发病率上升55%至19.2/10万,粗发病率上升77%至26.0/10万。
  • 同期年龄标化死亡率保持稳定,男性粗死亡率上升58%至4.1/10万,女性上升30%至3.0/10万。
  • 1970至2012年萨尔州年龄标化发病率增加超过四倍至13.1/10万,粗发病率增加六至七倍至18.5/10万。
  • 同期萨尔州男性年龄标化死亡率增加三倍至2.5/10万,女性增加两倍至1.6/10万;男性粗死亡率增加5.5倍至3.9/10万,女性增加3.5倍至3.2/10万,主要因≥60岁年龄组粗发病率和粗死亡率陡增。
  • 预计2030年男性粗发病率升至44-46/10万,女性升至38-40/10万;≥60岁患者增幅最陡,尤其是男性,40-59岁年龄组也预计增加,而<40岁者粗发病率预计稳定。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize incidence and mortality trends of cutaneous melanoma (CM) in Germany to extrapolate these data until 2030. METHODS: We evaluated data from the Centre for Cancer Registry Data (1999-2012) and from the Saarland Cancer Registry (1970-2012). Age-standardized (according to the European Standard Population, WHO 1976) incidence and mortality rates [age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs)] and crude incidence and mortality rates [crude incidence rates (CIRs) and crude mortality rates (CMRs)] were analysed. RESULTS: In entire Germany, ASIRs increased by 55% to 19.2 and CIRs by 77% to 26.0 new cases per 100 000 from 1999 to 2012. ASMRs remained stable, whereas CMR increased by 58% to 4.1 for males and by 30% to 3.0 for females per 100 000. In the Federal State of Saarland, ASIRs increased more than four-fold to 13.1, CIRs increased six-seven fold to 18.5/100 000 from 1970 to 2012. In the same period, ASMRs increased three-fold in males and two-fold in females to 2.5 and 1.6, whereas CMRs increased 5.5-fold in males and 3.5-fold in females to 3.9 and 3.2/100 000, mainly caused by steep increases of CIRs and CMRs in age groups ≥60 years. Projected CIRs will rise to 44-46 for males and 38-40 for females in 2030. Steepest increases were extrapolated for patients ≥60 years, especially for males, but are also expected for age groups of 40-59 years. In contrast, CIRs are anticipated to stabilize for subjects <40 years. CONCLUSIONS: There is a constant increase in incidence and mortality rates for CM in Germany. As the German population is ageing and the current population has already accumulated high levels of UV exposure, a further increase in melanoma incidence is projected for the future without signs of levelling-off.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Garbe C, Keim U, Eigentler TK, et al. Time trends in incidence and mortality of cutaneous melanoma in Germany. J Eur Acad Dermatol Venereol. 2019. PMID: 30387899. doi:10.1111/jdv.15322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。